Drugs / CSL200
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04091737 | Oct 2019 → May 2021 | sickle cell disease | CSL Behring | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CSL200 | “This is a phase 1 pilot study of CSL200 in adult subjects with severe sickle cell disease.” NCT04091737 ↗ |